Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 9/2017

11.08.2016 | Originalien

Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis

verfasst von: Y. H. Lee, MD, PhD, G. G. Song

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

We aimed to evaluate the relationship between circulating blood adipokine levels and systemic sclerosis (SSc).

Methods

We conducted a meta-analysis on serum/plasma adiponectin, leptin, or resistin levels in patients with SSc and controls, and performed a subgroup analysis based on ethnicity and/or disease type.

Results

Eleven studies (511 patients with SSc and 341 controls) were included in the meta-analysis. Meta-analysis revealed that adiponectin levels were significantly lower in patients with SSc than in controls (standardized mean differences [SMD] = −0.638; 95 % confidence intervals [CI] = −1.154, −0.122; P = 0.015). Stratification by ethnicity showed a low adiponectin level associated with SSc in Caucasians (SMD = −0.439; 95 % CI = −1.092, −0.213; P = 0.187) and Asians (SMD = −1.006; 95 % CI = −2.031, −0.019; P = 0.055), although this result was not statistically significant. Stratification by disease type revealed that the adiponectin level was significantly lower in the diffuse SSc, but not limited SSc, group than in the control (diffuse: SMD = −1.445; 95 % CI = −2.276, −0.614; P = 0.001; limited: SMD = 0.188; 95 % CI = −0.064, 0.439; P = 0.144). Meta-analysis showed no association between leptin levels and SSc (SMD = −0.029; 95 % CI = −1.362, 1.304; P = 0.966), and no association between resistin levels and SSc (SMD = 0.202; 95 % CI = −0.091, 0.496; P = 0.177).

Conclusions

Our meta-analysis revealed a significantly lower circulating adiponectin level in patients with SSc than in controls. This difference was apparent in the diffuse type of SSc, but not in the limited type. However, circulating leptin and resistin levels were not different between patients with SSc and healthy controls.
Literatur
1.
Zurück zum Zitat Gabrielli A, Avvedimento EV, Krieg Scleroderma T (2009) Scleroderma. N Engl J Med 360(19):1989–2003CrossRefPubMed Gabrielli A, Avvedimento EV, Krieg Scleroderma T (2009) Scleroderma. N Engl J Med 360(19):1989–2003CrossRefPubMed
3.
Zurück zum Zitat Shehzad A, Iqbal W, Shehzad O, Lee YS (2012) Adiponectin: regulation of its production and its role in human diseases. Hormones 11(1):8–20PubMed Shehzad A, Iqbal W, Shehzad O, Lee YS (2012) Adiponectin: regulation of its production and its role in human diseases. Hormones 11(1):8–20PubMed
4.
Zurück zum Zitat Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2):93–100CrossRefPubMedPubMedCentral Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2):93–100CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F et al (2011) Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors 37(6):413–420CrossRefPubMed Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F et al (2011) Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors 37(6):413–420CrossRefPubMed
6.
Zurück zum Zitat Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C et al (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010:Article ID 568343. doi:10.1155/2010/568343 CrossRef Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C et al (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010:Article ID 568343. doi:10.​1155/​2010/​568343 CrossRef
7.
Zurück zum Zitat Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA (2001) Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86(2):783–791PubMed Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA (2001) Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86(2):783–791PubMed
8.
Zurück zum Zitat Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174(9):5789–5795CrossRefPubMed Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174(9):5789–5795CrossRefPubMed
9.
Zurück zum Zitat Olewicz-Gawlik A, Danczak-Pazdrowska A, Kuznar-Kaminska B, Batura-Gabryel H, Katulska K, Wojciech S et al (2015) Circulating adipokines and organ involvement in patients with systemic sclerosis. Acta Reumatol Port 40(2):156–162PubMed Olewicz-Gawlik A, Danczak-Pazdrowska A, Kuznar-Kaminska B, Batura-Gabryel H, Katulska K, Wojciech S et al (2015) Circulating adipokines and organ involvement in patients with systemic sclerosis. Acta Reumatol Port 40(2):156–162PubMed
10.
Zurück zum Zitat Winsz-Szczotka K, Kuznik-Trocha K, Komosinska-Vassev K, Kucharz E, Kotulska A, Olczyk K (2014) Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients with systemic sclerosis: possible role in disease development. Int J Rheum Dis. doi:10.1111/1756-185x.12332 PubMed Winsz-Szczotka K, Kuznik-Trocha K, Komosinska-Vassev K, Kucharz E, Kotulska A, Olczyk K (2014) Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients with systemic sclerosis: possible role in disease development. Int J Rheum Dis. doi:10.​1111/​1756-185x.​12332 PubMed
11.
Zurück zum Zitat Budulgan M, Dilek B, Dag SB, Batmaz I, Yildiz I, Sariyildiz MA et al (2014) Relationship between serum leptin level and disease activity in patients with systemic sclerosis. Clin Rheumatol 33(3):335–339CrossRefPubMed Budulgan M, Dilek B, Dag SB, Batmaz I, Yildiz I, Sariyildiz MA et al (2014) Relationship between serum leptin level and disease activity in patients with systemic sclerosis. Clin Rheumatol 33(3):335–339CrossRefPubMed
12.
Zurück zum Zitat Masui Y, Asano Y, Akamata K, Aozasa N, Noda S, Taniguchi T et al (2014) Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis. Rheumatol Int 34(8):1165–1170CrossRefPubMed Masui Y, Asano Y, Akamata K, Aozasa N, Noda S, Taniguchi T et al (2014) Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis. Rheumatol Int 34(8):1165–1170CrossRefPubMed
13.
Zurück zum Zitat Lakota K, Wei J, Carns M, Hinchcliff M, Lee J, Whitfield ML et al (2012) Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14(3):R102CrossRefPubMedPubMedCentral Lakota K, Wei J, Carns M, Hinchcliff M, Lee J, Whitfield ML et al (2012) Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14(3):R102CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tomcik M, Arima K, Hulejova H, Kuklova M, Filkova M, Braun M et al (2012) Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine 58(2):165–168CrossRefPubMed Tomcik M, Arima K, Hulejova H, Kuklova M, Filkova M, Braun M et al (2012) Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine 58(2):165–168CrossRefPubMed
15.
Zurück zum Zitat Arakawa H, Jinnin M, Muchemwa FC, Makino T, Kajihara I, Makino K et al (2011) Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients. Exp Dermatol 20(9):764–766CrossRefPubMed Arakawa H, Jinnin M, Muchemwa FC, Makino T, Kajihara I, Makino K et al (2011) Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients. Exp Dermatol 20(9):764–766CrossRefPubMed
16.
Zurück zum Zitat Masui Y, Asano Y, Shibata S, Noda S, Aozasa N, Akamata K et al (2012) Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. J Eur Acad Dermatol Venereol 26(3):354–360CrossRefPubMed Masui Y, Asano Y, Shibata S, Noda S, Aozasa N, Akamata K et al (2012) Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. J Eur Acad Dermatol Venereol 26(3):354–360CrossRefPubMed
17.
Zurück zum Zitat Pehlivan Y, Onat AM, Ceylan N, Turkbeyler IH, Buyukhatipoglu H, Comez G et al (2012) Serum leptin, resistin and TNF-alpha levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis 15(4):374–379CrossRefPubMed Pehlivan Y, Onat AM, Ceylan N, Turkbeyler IH, Buyukhatipoglu H, Comez G et al (2012) Serum leptin, resistin and TNF-alpha levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis 15(4):374–379CrossRefPubMed
18.
Zurück zum Zitat Kotulska A, Kucharz EJ, Brzezinska-Wcislo L, Wadas U (2001) A decreased serum leptin level in patients with systemic sclerosis. Clin Rheumatol 20(4):300–302CrossRefPubMed Kotulska A, Kucharz EJ, Brzezinska-Wcislo L, Wadas U (2001) A decreased serum leptin level in patients with systemic sclerosis. Clin Rheumatol 20(4):300–302CrossRefPubMed
19.
Zurück zum Zitat Riccieri V, Stefanantoni K, Vasile M, Macrì V, Sciarra I, Iannace N et al (2011) Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 29(2 Suppl 65):46–52 Riccieri V, Stefanantoni K, Vasile M, Macrì V, Sciarra I, Iannace N et al (2011) Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 29(2 Suppl 65):46–52
20.
Zurück zum Zitat Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2009) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 37(1):227–234CrossRefPubMed Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2009) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 37(1):227–234CrossRefPubMed
21.
Zurück zum Zitat Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833CrossRefPubMed Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833CrossRefPubMed
22.
Zurück zum Zitat Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus 19(6):703–710CrossRefPubMed Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus 19(6):703–710CrossRefPubMed
23.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13CrossRefPubMedPubMedCentral Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
28.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed
29.
30.
Zurück zum Zitat Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463CrossRefPubMed Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463CrossRefPubMed
31.
Zurück zum Zitat Masui Y, Asano Y, Takahashi T, Shibata S, Akamata K, Aozasa N et al (2013) Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis. Mod Rheumatol 23(2):323–329CrossRefPubMed Masui Y, Asano Y, Takahashi T, Shibata S, Akamata K, Aozasa N et al (2013) Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis. Mod Rheumatol 23(2):323–329CrossRefPubMed
32.
Zurück zum Zitat Fang F, Liu L, Yang Y, Tamaki Z, Wei J, Marangoni RG et al (2012) The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther 14(5):R229CrossRefPubMedPubMedCentral Fang F, Liu L, Yang Y, Tamaki Z, Wei J, Marangoni RG et al (2012) The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther 14(5):R229CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K et al (2007) Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Investig 117(6):1718–1726CrossRefPubMedPubMedCentral Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K et al (2007) Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Investig 117(6):1718–1726CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Schöndorf T, Maiworm A, Emmison N, Forst T, Pfützner A (2005) Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab 51(9–10):489–494PubMed Schöndorf T, Maiworm A, Emmison N, Forst T, Pfützner A (2005) Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab 51(9–10):489–494PubMed
35.
Zurück zum Zitat Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O (2011) What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7(9):528–536CrossRefPubMed Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O (2011) What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7(9):528–536CrossRefPubMed
36.
Zurück zum Zitat Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gómez-Reino J et al (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology 45(8):944–950CrossRefPubMed Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gómez-Reino J et al (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology 45(8):944–950CrossRefPubMed
38.
Zurück zum Zitat Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T‑cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901CrossRefPubMed Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T‑cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901CrossRefPubMed
39.
Zurück zum Zitat Wronkowitz N, Romacho T, Sell H, Eckel J (2014) Adipose tissue dysfunction and inflammation in cardiovascular disease. Front Horm Res 43:79–92PubMed Wronkowitz N, Romacho T, Sell H, Eckel J (2014) Adipose tissue dysfunction and inflammation in cardiovascular disease. Front Horm Res 43:79–92PubMed
Metadaten
Titel
Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis
verfasst von
Y. H. Lee, MD, PhD
G. G. Song
Publikationsdatum
11.08.2016
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 9/2017
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-016-0172-5

Weitere Artikel der Ausgabe 9/2017

Zeitschrift für Rheumatologie 9/2017 Zur Ausgabe

Mitteilungen des BDRh

Mitteilungen des BDRh

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.